Product reference image is not available in the current asset
directory. Verify the matching image filename before publishing.
Reference image only. Tablet colour, shape, packaging and imprints cannot
prove authenticity, ingredients or authorization. Confirm the exact product with a licensed
pharmacist.
Opioid combination pain medicinePrescription medicine / verification required
Hydro Watson
Hydro Watson refers to historic Watson-imprint hydrocodone/acetaminophen
combination tablets. The medicine reference describes several different imprint-to-strength
associations, so the catalogue name alone does not identify a single strength or tablet.
Medicine identity
referenceHydrocodone bitartrate + acetaminophen
(specific strength depends on tablet imprint)Immediate-release combination tablet referencesSchedule II controlled substance (United States)
Prescription and identity verification
required
This is an educational information page, not a sales listing. It does not accept orders,
collect payment, or verify a prescription. Use only an appropriately licensed pharmacy
and a valid prescription from a qualified prescriber. Do not use an image or informal
seller description to identify a tablet.
Source basis: Chapter 8 (Hydro Watson), printed pages 18–20, in the
supplied Detailed Medicine Reference Guide (compiled October 2026). Medical review
status: clinician verification pending.
Product description and identification
The guide describes Watson-imprint products as hydrocodone bitartrate combined with
acetaminophen (paracetamol). It lists examples including Watson 853 (10mg/325mg), Watson 540
(10mg/500mg) and Watson 385 (7.5mg/325mg). These are different strengths and should not be
treated as interchangeable.
Watson Pharmaceuticals became part of a corporate lineage that later included Actavis,
Allergan and Teva generics. The source also notes that many Watson imprints remain in
circulation and have been copied.
Clinical context described in the reference
The reference describes hydrocodone/acetaminophen combinations as used for acute pain severe
enough to require an opioid when non-opioid options are inadequate, typically over short
courses. The exact approved indication and strength depend on the specific authorized
product label.
Imprint and strength verification
The reference gives these examples: Watson 853 = 10/325, Watson 540 = 10/500, and Watson 385
= 7.5/325. Because the catalogue entry does not specify an imprint, the exact strength
cannot be confirmed from the name “Hydro Watson”.
Watson-imprint tablets have been imitated in illicit markets. Only a pharmacy-issued
container and verified prescription establish a reliable source.
Important safety warnings
Opioid boxed warnings include fatal respiratory depression, addiction, abuse and misuse,
neonatal opioid withdrawal and dangerous sedation with benzodiazepines or other depressants.
Acetaminophen adds risk of acute liver injury, particularly with overdose, alcohol or
multiple acetaminophen-containing products.
Accidental ingestion by a child can be fatal. Treat any unidentified tablet as unknown rather
than relying on a visual match.
Possible side effects
Common effects include nausea, vomiting, constipation, drowsiness, dizziness, headache, dry
mouth and sweating. Serious signs include slow breathing or unresponsiveness, and
liver-injury signs such as abdominal pain, jaundice or dark urine.
Drug and alcohol interactions
Alcohol, benzodiazepines, sleep medicines, other opioids, carisoprodol and sedating
antihistamines can deepen sedation and breathing depression. Multiple acetaminophen products
can increase liver-injury risk. The guide also describes interactions involving CYP3A4,
enzyme inducers, warfarin, serotonergic medicines and MAOIs.
Pregnancy, breastfeeding and other precautions
Regular use during pregnancy may cause neonatal opioid withdrawal. Both active ingredients
can pass into breast milk and infant sedation has been reported. Older adults and people
with lung disease or sleep apnoea require careful professional review.
Storage and handling
Keep the exact verified product in its original labelled container, locked away from children
and other people. Return leftovers through a pharmacy take-back program. The guide notes
that Watson imprints can be copied.
Medicine identity at a glance
Active ingredient
Hydrocodone bitartrate + acetaminophen (specific strength depends on tablet
imprint)
Formulation reference
Immediate-release combination tablet references
Regulatory context
Schedule II controlled substance (United States)
Brand / identity reference
Watson imprints; Norco and generic-equivalent family references
Important safety information: Many medicines described here are
controlled or can cause serious harm. Keep them away from children and unauthorized users, avoid
unapproved combinations, and use only medicine supplied by a licensed pharmacy under a valid
prescription.
Patient information
Hydro Watson: medicine information and safety overview
At a glance
Hydro Watson refers to historic Watson-imprint hydrocodone/acetaminophen combination tablets.
The medicine reference describes several different imprint-to-strength associations, so the
catalogue name alone does not identify a single strength or tablet.
This guide page summarizes the supplied medicine-reference chapter. It is not a personalized
recommendation, a product-authentication service, or a substitute for the official package
leaflet. The exact formulation and manufacturer's authorization should be checked for the
product actually dispensed.
These links are starting points for official or patient-facing information.
Always check the leaflet and label for the precise product, manufacturer and jurisdiction.
Frequently asked questions
The guide describes historic Watson-imprint hydrocodone and acetaminophen combination
tablets.
The name alone does not specify a single strength. The reference lists several
different Watson imprints and strengths.
Yes. The guide identifies hydrocodone combination products as Schedule II in the
United States.
No. Imprints can be copied; use only medicines from an authorized pharmacy.